Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD) is a fatal genetic muscle wasting disease with no current cure. A prominent, yet poorly treated feature of dystrophic muscle is the dysregulation of energy homeostasis which may be associated with intrinsic defects in key energy systems and promote muscle wasting. A...
Main Authors: | Emma Rybalka, Cara A. Timpani, Christos G. Stathis, Alan Hayes, Matthew B. Cooke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6643/7/12/5498 |
Similar Items
-
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy
by: Cara A. Timpani, et al.
Published: (2017-05-01) -
Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
by: Cara A. Timpani, et al.
Published: (2020-12-01) -
Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
by: Stephanie Kourakis, et al.
Published: (2021-01-01) -
Nutriceutical effects of fermented <em>Parkia biglobosa</em> seeds on recovery of malnourished rats
by: K. T. Biobaku, et al.
Published: (2017-09-01) -
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.